Trial Profile
Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and QOL in MS Patients
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Bee venom (Primary) ; Histamine
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Apimeds
- 25 Oct 2018 New trial record